Driven by the increasing adoption of non-viral drug delivery technologies in the healthcare sector, we anticipate The global non-viral drug delivery systems market for healthcare to grow at an annualized rate of ~14%, till 2035
The global demand for biologics currently holds the largest share in the non-viral drug delivery domain and is expected to show the similar trend in the coming years.
For additional details, please visit https://www.rootsanalysis.com/....reports/non-viral-dr or email sales@rootsanalysis.com
